Consulting / Advisory Firm · +1 more type
Products: Twine, Narralytix +1 more
“We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio.”Source: bluematterconsulting.com
Also offers: Product Launch Strategy & Readiness, Market Access Strategy & Launch Planning, +1 more
Data / Intelligence Provider · +3 more types
Products: Evaluate Pharma, Evaluate Omnium
“With a team of over 70 consultants globally, extensive data assets, and experience across therapy areas and modalities, we specialise in the areas of Portfolio Strategy, Licensing…”Source: evaluate.com
Also offers: Competitive Intelligence, Business Development, Licensing & Due Diligence, +1 more
Consulting / Advisory Firm · +3 more types
Products: ZAIDYN, ZS Trials.ai +3 more
“…ZS’s approach to portfolio strategy and management Deliver greater portfolio value, leveraging ZS’s deep industry expertise and advanced analytics to create actionable strategies…”Source: zs.com
Also offers: Segmentation, Targeting & Call Planning, Medical Insights Management, +6 more
Consulting / Advisory Firm · +2 more types
“Indication Assessment and Prioritization (IAP) forms the cornerstone of strategic evaluation for identified indications, leveraging key parameters to determine their potential…”Source: hallorancg.com
Also offers: Regulatory Development Strategy & Agency Interactions, GxP Compliance Consulting, +2 more
Consulting / Advisory Firm · +4 more types
Products: Lumanity Illuminator, Evidence Illuminator +9 more
“Prioritizing and sequencing your pipeline for your programs or platform at an early stage, while considering future factors such as clinical feasibility, regulatory agencies, and…”Source: lumanity.com
Also offers: Market Access Strategy & Launch Planning, Brand Strategy & Positioning, +2 more
Service Provider · +3 more types
Products: TrinityEDGE, InsightsEDGE +6 more
“Analysis: Valuations, profitability, risk-adjusted portfolio assessments, and peer benchmarking”Source: trinitylifesciences.com
Also offers: Market Research & Primary Insights, Product Launch Strategy & Readiness, +2 more
Agency · +4 more types
“Asset and development strategy, feasibility, and integrated evidence generation and planning.”Source: envisionpharmagroup.com
Also offers: Publication Planning & Management, Scientific Communications Strategy, +1 more
Consulting / Advisory Firm · +2 more types
“…Beyond the Asset Decisions don’t happen in isolation. We help clients think across therapy areas and portfolios, identifying where science aligns, where unmet need clusters, and…”Source: openhealthgroup.com
Also offers: HTA Strategy & Submissions, RWE for Access & HEOR, +3 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“…Enhance your portfolio strategy and manage risk effectively with evidence-based decisions. Understand market dynamics, evaluate pipeline assets and prioritize products based on…”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
What this covers: Advisory services focused on prioritizing assets, optimizing portfolios, sequencing indications, lifecycle strategy, resource allocation, and strategic decisions across pipeline or marketed product portfolios.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Blue Matter Consulting | Consulting / Advisory Firm | Corporate & Growth Strategy, R&D and Innovation Strategy | “We help customers optimize their investments across therapeutic areas and across assets within any given therapeutic portfolio.”bluematterconsulting.com · reviewed Oct 21, 2026 |
| Envision Pharma Group | Agency | — | “Asset and development strategy, feasibility, and integrated evidence generation and planning.”envisionpharmagroup.com · reviewed Oct 18, 2026 |
| Evaluate | Data / Intelligence Provider | Corporate & Growth Strategy | “With a team of over 70 consultants globally, extensive data assets, and experience across therapy areas and modalities, we specialise in the areas of Portfolio…”evaluate.com · reviewed Oct 20, 2026 |
| Halloran Consulting Group | Consulting / Advisory Firm | R&D and Innovation Strategy | “Indication Assessment and Prioritization (IAP) forms the cornerstone of strategic evaluation for identified indications, leveraging key parameters to determine…”hallorancg.com · reviewed Oct 21, 2026 |
| IQVIA | CRO / Research Services Provider | — | “…Enhance your portfolio strategy and manage risk effectively with evidence-based decisions. Understand market dynamics, evaluate pipeline assets and prioritize…”iqvia.com · reviewed Oct 19, 2026 |
| Lumanity | Consulting / Advisory Firm | Corporate & Growth Strategy | “Prioritizing and sequencing your pipeline for your programs or platform at an early stage, while considering future factors such as clinical feasibility…”lumanity.com · reviewed Oct 21, 2026 |
| OPEN Health | Consulting / Advisory Firm | — | “…Beyond the Asset Decisions don’t happen in isolation. We help clients think across therapy areas and portfolios, identifying where science aligns, where unmet…”openhealthgroup.com · reviewed Oct 24, 2026 |
| Trinity Life Sciences | Service Provider | Corporate & Growth Strategy | “Analysis: Valuations, profitability, risk-adjusted portfolio assessments, and peer benchmarking”trinitylifesciences.com · reviewed Oct 21, 2026 |
| ZS | Consulting / Advisory Firm | Corporate & Growth Strategy, R&D and Innovation Strategy | “…ZS’s approach to portfolio strategy and management Deliver greater portfolio value, leveraging ZS’s deep industry expertise and advanced analytics to create…”zs.com · reviewed Oct 24, 2026 |